Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,486 | 115 | 104 | 176 | 314 |
| Cost of Goods | 891 | 65 | 54 | 131 | 431 |
| Gross Profit | 595 | 50 | 50 | 45 | -117 |
| Operating Expenses | 35,113 | 13,630 | 4,736 | 9,443 | 16,493 |
| Operating Income | -33,627 | -13,515 | -4,632 | -9,267 | -16,179 |
| Interest Expense | 30 | 31 | 8 | 15 | 13 |
| Other Income | 146 | 53 | 110 | 153 | 200 |
| Pre-tax Income | -33,511 | -13,493 | -4,530 | -9,129 | -15,992 |
| Net Income Continuous | -33,511 | -13,493 | -4,530 | -9,129 | -15,992 |
| Net Income | $-33,511 | $-13,493 | $-4,530 | $-9,129 | $-15,992 |
| EPS Basic Total Ops | -2.19 | -0.98 | -0.36 | -1.13 | -2.27 |
| EPS Basic Continuous Ops | -2.20 | -0.98 | -0.35 | -1.10 | -2.31 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.04 |
| EPS Diluted Total Ops | -2.19 | -0.98 | -0.36 | -1.13 | -2.27 |
| EPS Diluted Continuous Ops | -2.20 | -0.98 | -0.35 | -1.10 | -2.31 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.04 |
| EPS Diluted Before Non-Recurring Items | 0.48 | -0.98 | -0.36 | N/A | N/A |
| EBITDA(a) | $-33,064 | $-13,175 | $-4,306 | $-8,932 | $-15,854 |